Bosh sahifaLUPIN • NSE
add
Lupin Ltd
Yopilish kursi
2 154,45 ₹
Kunlik diapazon
2 136,40 ₹ - 2 179,05 ₹
Yillik diapazon
1 368,25 ₹ - 2 402,90 ₹
Bozor kapitalizatsiyasi
983,48 mlrd INR
Oʻrtacha hajm
1,01 mln
Narx/foyda
37,58
Dividend daromadliligi
0,37%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 56,73 mlrd | 12,59% |
Joriy xarajat | 28,73 mlrd | 7,98% |
Sof foyda | 8,53 mlrd | 74,12% |
Sof foyda marjasi | 15,03 | 54,63% |
Har bir ulushga tushum | 18,64 | 73,88% |
EBITDA | 13,62 mlrd | 48,62% |
Amaldagi soliq stavkasi | 18,52% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 29,12 mlrd | 68,06% |
Jami aktivlari | 254,82 mlrd | 8,69% |
Jami passivlari | 97,62 mlrd | -3,69% |
Umumiy kapital | 157,20 mlrd | — |
Tarqatilgan aksiyalar | 455,95 mln | — |
Narxi/balansdagi bahosi | 6,28 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 15,22% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 8,53 mlrd | 74,12% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Tashkil etilgan
1968
Bosh ofis
Sayt
Xodimlar soni
19 210
